- Filed
- Dec 15, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2017 · Dec 1, 2017 | 13.22M sh |
| Shares Diluted | FY 2017 · Sep 30, 2016 | 13.22M sh |
| Capex | FY 2017 · Sep 30, 2016 | $385K |
| Operating Cash Flow | FY 2017 · Sep 30, 2016 | −$8.99M |
| Current Liabilities | FY 2017 · Sep 30, 2016 | $32.17M |
| Total Liabilities | FY 2017 · Sep 30, 2016 | $41.4M |
| Current Assets restated | FY 2017 · Sep 30, 2016 | $21.99M |
| Total Assets | FY 2017 · Sep 30, 2016 | $31.61M |
| Sga Expense | FY 2017 · Sep 30, 2016 | $18.9M |
| Rd Expense | FY 2017 · Sep 30, 2016 | $5.13M |
| Net Income | FY 2017 · Sep 30, 2016 | −$12.7M |
| Operating Income | FY 2017 · Sep 30, 2016 | −$12.5M |
| Gross Profit | FY 2017 · Sep 30, 2016 | $31.42M |
| Cost Of Revenue | FY 2017 · Sep 30, 2016 | $50.16M |
| Revenue | FY 2017 · Sep 30, 2016 | $81.59M |
| Cash And Equivalents | FY 2017 · Oct 2, 2015 | $17.94M |
| Stockholders Equity | FY 2017 · Oct 2, 2015 | $3.05M |